[HTML][HTML] How to manage Pseudomonas aeruginosa infections

M Bassetti, A Vena, A Croxatto, E Righi, B Guery - Drugs in context, 2018 - ncbi.nlm.nih.gov
Infections with Pseudomonas aeruginosa have become a real concern in hospital-acquired
infections, especially in critically ill and immunocompromised patients. The major problem …

Community-acquired pneumonia and hospital-acquired pneumonia

CW Lanks, AI Musani, DW Hsia - Medical Clinics, 2019 - medical.theclinics.com
Community-acquired Pneumonia and Hospital-acquired Pneumonia - Medical Clinics Skip to
Main Content Skip to Main Menu Medical Clinics Log in Register Log in Subscribe Claim Main …

Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease

W Liu, ZW Tao, L Wang, ML Yuan, K Liu… - Chinese medical …, 2020 - mednexus.org
Background Since early December 2019, the 2019 novel coronavirus disease (COVID-19)
has caused pneumonia epidemic in Wuhan, Hubei province of China. This study aimed to …

Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia

GU Meduri, MC Shih, L Bridges, TJ Martin… - Intensive care …, 2022 - Springer
Purpose Severe community-acquired pneumonia (CAP) requiring intensive care unit
admission is associated with significant acute and long-term morbidity and mortality. We …

Predictors of in-hospital mortality in older patients with COVID-19: the COVIDAge study

A Mendes, C Serratrice, FR Herrmann, L Genton… - Journal of the American …, 2020 - Elsevier
Objective To determine predictors of in-hospital mortality related to COVID-19 in older
patients. Design Retrospective cohort study. Setting and Participants Patients aged 65 years …

Management of pneumonia in critically ill patients

C Cillóniz, A Torres, MS Niederman - bmj, 2021 - bmj.com
Severe pneumonia is associated with high mortality (short and long term), as well as
pulmonary and extrapulmonary complications. Appropriate diagnosis and early initiation of …

Microbial etiology of pneumonia: epidemiology, diagnosis and resistance patterns

C Cilloniz, I Martin-Loeches, C Garcia-Vidal… - International journal of …, 2016 - mdpi.com
Globally, pneumonia is a serious public health concern and a major cause of mortality and
morbidity. Despite advances in antimicrobial therapies, microbiological diagnostic tests and …

Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community …

A Torres, F Blasi, N Dartois, M Akova - Thorax, 2015 - thorax.bmj.com
Pneumococcal disease (including community-acquired pneumonia and invasive
pneumococcal disease) poses a burden to the community all year round, especially in those …

Pneumococcal infection in adults: burden of disease

JJC Drijkoningen, GGU Rohde - Clinical Microbiology and …, 2014 - Wiley Online Library
To overview the present global burden of pneumococcal disease is important because new
preventive measures such as the pneumococcal conjugate vaccine 13 are currently being …

Diagnosis and treatment of community‐acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association

B Cao, Y Huang, DY She, QJ Cheng… - The clinical …, 2018 - Wiley Online Library
Community‐acquired pneumonia (CAP) in adults is an infectious disease with high
morbidity in China and the rest of the world. With the changing pattern in the etiological …